Construction has begun on the second building in the Phil and Penny Knight Campus for Scientific Impact, following the formal approval of the budget by the University of Oregon Board of Trustees on Dec. 6, 2022. Building 2 is a 185,000-square-foot, multi-story bioengineering and applied science research facility located along Riverfront Research Parkway.

Building 2 is part of the second phase of Knight Campus development, which will double the campus’ capacity for research and development of new biomedical technologies with additional room for expanding academic programs, spin spaces to incubate new startup companies and a state-of-the-art new core facility. It will include the second of two Papé Family Innovation Center facilities, offering individual modules that companies can lease, and providing flexibility for different kinds of startup companies.

Phase 2 of Knight Campus development is made possible by a second $500 million gift from Penny and Phil Knight for the campus bearing their names. Additionally, the Oregon legislature has approved $10 million to support cutting-edge technologies in Knight Campus building 2.

“State investment will support the build-out of a real-time, machine-learning-fueled integrated tissue characterization and bioprinting facility that will catalyze research to open new avenues in personalized medicine," said Robert Guldberg, Vice President and Robert and Leona DeArmond Executive Director. "Building 2 furthers our mission of science advancing society, providing more spaces where teams of world-class bioengineers, accompanied by outstanding students, will drive groundbreaking scientific research and furthering opportunities for interdisciplinary, hands-on training that equips the next generation of applied scientists with the skills to tackle real-world problems."

Building 2 construction is currently on schedule. For a construction timeline and future developments, visit the Building 2 webpage .